Holen Sie sich die Stockscreener-App
86.53
0.37%
0.32
Handel nachbörslich:
86.53
Vaxcyte Inc Aktie (PCVX) Neueste Nachrichten
Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset - MSN
Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset (PCVX:NASDAQ) - Seeking Alpha
The Goldman Sachs Group Begins Coverage on Vaxcyte (NASDAQ:PCVX) - MarketBeat
Vaxcyte stock supported by Goldman Sachs for addressing next-gen vaccine challenges - Investing.com
Vaxcyte's president and CFO sells $710,248 in stock transactions - Investing.com India
Vaxcyte's president and CFO sells $710,248 in stock transactions By Investing.com - Investing.com Canada
Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CFO Sells 8,000 Shares of Stock - MarketBeat
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm - EIN News
(PCVX) Investment Report - Stock Traders Daily
Lord Abbett & CO. LLC Raises Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Franklin Resources Inc. Raises Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Geode Capital Management LLC Buys 259,010 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Receives $147.50 Average Price Target from Analysts - MarketBeat
Applied Industrial Technologies (AIT-N) QuotePress Release - The Globe and Mail
Merck & Company (MRK-N) QuotePress Release - The Globe and Mail
Why Wall Street Rates These 2 Russell 2000 Stocks a “Strong Buy” - MSN
Pfizer Inc (PFE-N) QuotePress Release - The Globe and Mail
Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life ScienceSan Carlos Mega Campus (PR Newswire) - Aktiellt
Vaxcyte, Inc. (NASDAQ:PCVX) is Frazier Life Sciences Management L.P.'s 7th Largest Position - MarketBeat
Y Intercept Hong Kong Ltd Increases Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Zacks Investment Management Acquires Shares of 13,645 Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
State Street Corp Increases Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
What Makes Vaxcyte (PCVX) An Investment Bet? - MSN
Vaxcyte's SVP Mikhail Eydelman sells $457k in stock By Investing.com - Investing.com UK
Stocks With Rising Relative Strength: Vaxcyte - MSN
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely - Simply Wall St
Pier Capital LLC Reduces Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
(PCVX) Trading Signals - Stock Traders Daily
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by RA Capital Management L.P. - MarketBeat
Point72 Asset Management L.P. Takes Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Polar Asset Management Partners Inc. Sells 44,200 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Bank of Montreal Can Invests $3.10 Million in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants - Yahoo! Voices
Parkman Healthcare Partners LLC Trims Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Maven Securities LTD Acquires Shares of 129,700 Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Bamco Inc. NY Makes New $3.54 Million Investment in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Vaxcyte CEO Grant Pickering sells $1.39 million in stock By Investing.com - Investing.com Canada
Vaxcyte CEO Grant Pickering sells $1.39 million in stock - Investing.com
Vaxcyte COO Jim Wassil sells $739,884 in stock By Investing.com - Investing.com UK
Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants - GlobeNewswire
Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal - The Bakersfield Californian
HighVista Strategies LLC Grows Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Cinctive Capital Management LP Purchases Shares of 32,494 Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by The Manufacturers Life Insurance Company - MarketBeat
Braidwell LP Sells 510,735 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Fred Alger Management LLC Reduces Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Eventide Asset Management LLC Has $43.82 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaccine maker doubles its space at Bay Area biotech mega-campus - MSN
Acuta Capital Partners LLC Has $15.47 Million Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug - MSN
Fmr LLC Sells 366,673 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Citigroup Inc. Grows Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Fast-growing vaccine developer doubles San Carlos headquarters - The Business Journals
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):